SECsense Logo

Biogen Inc. 8-K Report: Key Corporate Developments on January 13, 2025

$BIIB
Form 8-K
Filed on: 2025-01-15
Source
Biogen Inc. 8-K Report: Key Corporate Developments on January 13, 2025

Here’s a summary of the key information extracted from the provided section of the financial report:

  1. Filing Type: 8-K (a report of unscheduled material events or corporate changes that could be of importance to shareholders).
  2. Company Information:
  • Company Name: Biogen Inc.
  • State of Incorporation: Delaware (DE).
  • Address: 225 Binney Street, Cambridge, MA 02142.
  • Phone Number: (617) 679-2000.
  1. Identifiers:
  • CIK Number: 0000875045 (Central Index Key used by the SEC).
  • SEC File Number: 0-19311.
  • IRS Employer Identification Number: 33-0112644.
  1. Stock Information:
  • Common Stock Par Value: $0.0005.
  • Ticker Symbol: BIIB (listed on NASDAQ).
  1. Filing Date: The report is dated January 13, 2025.
  2. Reporting Period: The context indicates a reporting period from January 13, 2025, to January 13, 2025, which suggests a specific event or occurrence on that date.

This 8-K filing implies that Biogen Inc. reported a significant event or development that shareholders and the market need to be aware of on January 13, 2025. Further details would be necessary to understand the specifics of the event reported in this filing.